Shares of Guardant Health Inc. (GH) are soaring 5.02% in intraday trading, following a bullish analyst report from Piper Sandler. The healthcare company's stock is gaining momentum as investors react positively to the reaffirmed Buy rating.

David Westenberg, an analyst at Piper Sandler, maintained a Buy rating on Guardant Health with a price target of $60.00. This vote of confidence from a respected financial institution appears to be driving the stock's upward movement. The price target suggests significant upside potential from the stock's current trading levels.

The reaffirmation of the Buy rating could be bolstering investor confidence in Guardant Health's future prospects. As a company operating in the competitive healthcare sector, positive analyst coverage often serves as a catalyst for stock price appreciation. Investors may be interpreting this maintained rating as a sign of the company's strong market position and growth potential.